Small Intestinal Bacterial Overgrowth and Rifaximin: An Update

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

TALEBI BEZMIN ABADI AMIN

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: GOVARESH JOURNAL Year:2019 | Volume:23 | Issue:4 Page(s): 238-241

Download Full-Text

View:

128

Download:

102

Cites:

Information Journal Paper

Title

Small Intestinal Bacterial Overgrowth and Rifaximin: An Update

Author(s)

TALEBI BEZMIN ABADI AMIN | Issue Writer Certificate

Keywords

Small intestinal bacterial overgrowth

Rifaximin

Rifamycin

Microbiota

Antibiotic

Treatment

Abstract

Excessive bacteria and nutrient malabsorption are the two major events need to clarify Small intestinal bacterial overgrowth (SIBO). Clinically, SIBO is defined as a condition with the existence of > 106 colony-forming units (CFU) bacteria in the human intestine. It is the only generally accepted criteria to diagnose the SIBO in clinical practice. The main problem is that several clinical disorders are happening in patients with SIBO; thus actual discrimination will be relatively difficult. Exploration of the current status of SIBO management and suggesting Rifaximin as a main clinical target is our optimal goal. Although the quality of performed randomized clinical trials needs to be re-evaluated, Rifaximin seems the only suitable option for Treatment of SIBO. Undoubtedly, new Treatment should include the correction of ongoing small intestinal microflora with proper Antibiotic therapy. Personalized medicine is another option that should be studied thoroughly before entering the area of SIBO treating using proton pump inhibitors. Finally, we have to focus on the available option to have better management of patients with SIBO.

Cites

No record.

References

No record.

Cite

APA: Copy

TALEBI BEZMIN ABADI, AMIN. (2019). Small Intestinal Bacterial Overgrowth and Rifaximin: An Update. GOVARESH JOURNAL, 23(4 ), 238-241. SID. https://sid.ir/paper/773146/en

Vancouver: Copy

TALEBI BEZMIN ABADI AMIN. Small Intestinal Bacterial Overgrowth and Rifaximin: An Update. GOVARESH JOURNAL[Internet]. 2019;23(4 ):238-241. Available from: https://sid.ir/paper/773146/en

IEEE: Copy

AMIN TALEBI BEZMIN ABADI, “Small Intestinal Bacterial Overgrowth and Rifaximin: An Update,” GOVARESH JOURNAL, vol. 23, no. 4 , pp. 238–241, 2019, [Online]. Available: https://sid.ir/paper/773146/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops